BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24895506)

  • 1. Usefulness of Combined Metabolic-Volumetric Indices of (18)F-FDG PET/CT for the Early Prediction of Neoadjuvant Chemotherapy Outcomes in Breast Cancer.
    Im HJ; Kim YK; Kim YI; Lee JJ; Lee WW; Kim SE
    Nucl Med Mol Imaging; 2013 Mar; 47(1):36-43. PubMed ID: 24895506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of baseline and interim [
    Yadgarov MY; Dunaykin MM; Shestopalov GI; Kailash C; Kireeva ED; Myakova NV; Likar YN
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1955-1964. PubMed ID: 38351389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Innovative Non-Linear Prediction Model for Clinical Benefit in Women with Newly Diagnosed Breast Cancer Using Baseline FDG-PET/CT and Clinical Data.
    Kudura K; Ritz N; Templeton AJ; Kutzker T; Hoffmann MHK; Antwi K; Zwahlen DR; Kreissl MC; Foerster R
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001736
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlation between
    Chen B; Tao J; Wu T; Feng H; Xie J; Zhong L; Wang S
    Quant Imaging Med Surg; 2023 Dec; 13(12):7842-7853. PubMed ID: 38106249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volume-based
    Liu DN; Li CP; Li HW; Wang HY; Tian XY; Hao CY
    Abdom Radiol (NY); 2024 Mar; 49(3):958-963. PubMed ID: 38245900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of [
    Civan C; Ozkan ZG; Ozkan B; Isik EG; Erdogdu E; Has Simsek D; Duman S; Sanli Y; Kara M; Kuyumcu S; Toker A
    Cancer Biother Radiopharm; 2024 Mar; ():. PubMed ID: 38484307
    [No Abstract]   [Full Text] [Related]  

  • 7. Preoperative metabolic parameters of
    Lu X; Wang G; Feng L; Kan Y; Wang W; Yang J; Zhang M
    Quant Imaging Med Surg; 2024 Jan; 14(1):462-475. PubMed ID: 38223114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal Nasopharyngeal Activity Detected on [
    Wong WC
    Nucl Med Mol Imaging; 2022 Dec; 56(6):299-305. PubMed ID: 36425278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of Dynamic
    Kupik O; Tuncel M; Özgen Kıratlı P; Akpınar MG; Altundağ K; Başaran Demirkazık F; Erbaş B
    Mol Imaging Radionucl Ther; 2023 Jun; 32(2):94-102. PubMed ID: 37337702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative
    Aymard S; Rust E; Kaseb A; Liu D; Hubele F; Romain B; Averous G; Brigand C; Imperiale A
    Cancers (Basel); 2024 Jan; 16(1):. PubMed ID: 38201660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective pilot study utilizing changes in quantitative values obtained on serial fluorine-18 fluorodeoxyglucose (
    Martin TW; Griffin L
    Vet Radiol Ultrasound; 2024 Apr; ():. PubMed ID: 38655687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volume of interest delineation techniques for
    Stevenson MG; Been LB; Hoekstra HJ; Suurmeijer AJH; Boellaard R; Brouwers AH
    EJNMMI Res; 2018 Jun; 8(1):42. PubMed ID: 29881881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated quantification of baseline imaging PET metrics on FDG PET/CT images of pediatric Hodgkin lymphoma patients.
    Weisman AJ; Kim J; Lee I; McCarten KM; Kessel S; Schwartz CL; Kelly KM; Jeraj R; Cho SY; Bradshaw TJ
    EJNMMI Phys; 2020 Dec; 7(1):76. PubMed ID: 33315178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are MTV and TLG Accurate for Quantifying the Intensity of Brown Adipose Tissue Activation?
    Jalloul W; Moscalu M; Moscalu R; Jalloul D; Grierosu IC; Gutu M; Haba D; Mocanu V; Gutu MM; Stefanescu C
    Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of (F-18) Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Prediction of Response to Neoadjuvant Therapy in Esophageal Cancer: Correlation with Pathological Response and Survival.
    Robles Barba JJ; Llobera AS; Cenzano CG; Martin Marcuartu JJ; Martínez NR; Paules Villar MJ; Larrañaga CB; Inglada AB; Campos MC; Pous AF; Guzmán MG; Romera MC
    Indian J Nucl Med; 2023; 38(2):97-102. PubMed ID: 37456192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of intratumoral-metabolic heterogeneity derived from
    Zhang L; Liu Y; Ding Y; Deng Y; Chen H; Hu F; Fan J; Lan X; Cao W
    Front Oncol; 2023; 13():1065744. PubMed ID: 37182124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prognostic Role of [
    Filippi L; Proietti I; Petrozza V; Potenza C; Bagni O; Schillaci O
    Cancer Biother Radiopharm; 2024 Feb; 39(1):46-54. PubMed ID: 37883658
    [No Abstract]   [Full Text] [Related]  

  • 18. A different perspective on PET/CT before treatment in patients with Hodgkin lymphoma: importance of volumetric and dissemination parameters.
    Aksu A; Küçüker KA; Solmaz Ş; Turgut B
    Ann Hematol; 2024 Mar; 103(3):813-822. PubMed ID: 37964021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactate Dehydrogenase A is Associated with Elevated FDG Metabolism, Radioiodine Non-avidity, and Poor Prognosis in Differentiated Thyroid Cancer.
    Tian T; Dai H; Zhang M; Su M; Chen X; Huang R
    Acad Radiol; 2024 Jun; ():. PubMed ID: 38866688
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Diwanji D; Onishi N; Hathi DK; Lawhn-Heath C; Kornak J; Li W; Guo R; Molina-Vega J; Seo Y; Flavell RR; Heditsian D; Brain S; Esserman LJ; Joe BN; Hylton NM; Jones EF; Ray KM
    Radiol Imaging Cancer; 2024 Mar; 6(2):e230082. PubMed ID: 38551406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.